MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-36-0011004
Medopex Remedies Private Limited
Medopex Remedies Private Limited - pharma in Yavatmal, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.56 Lakh
▲ 72% YoY
Net profit · FY 2025
₹1,530
Net margin 0.2%
EBITDA · FY 2025
₹1,530
EBITDA margin 0.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹4 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Medopex Remedies Private Limited
Data last updated:
Medopex Remedies Private Limited is a private limited company based in Yavatmal, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51101MH2015PTC268301. Its GSTIN is 27AAJCM9458L1ZM (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priti Satish Purohit and Satish Indarchand Purohit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 28 Wadgaon Road Shradha Nagar, Yavatmal, Maharashtra, India – 445001.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.56 Lakh, a growth of 72% compared to the previous year. For the same year it recorded a net profit of ₹1,530 (net margin 0.2%) and EBITDA of ₹1,530 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 17% over five years.
As per MCA filings, the company has open charges of ₹4 Lakh on record.
Medopex Remedies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-36-0011004). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51101MH2015PTC268301
Registration Number 268301
Incorporation Date 10 September 2015
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-36-0011004
Recognitions & Rankings of Medopex Remedies
Contact details
Medopex Remedies Private Limited's registered office is in Yavatmal, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address28 Wadgaon Road Shradha Nagar, Yavatmal, Maharashtra, India – 445001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medopex Remedies Private Limited, buy the company report.
Comprehensive company report
Medopex Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medopex Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medopex Remedies Private Limited, buy the company report.
Financials of Medopex Remedies Private Limited
FY 2025 filings availableMedopex Remedies Private Limited reported revenue of ₹7.56 Lakh (up 72% YoY) for FY 2025.
Revenue · FY 2025
₹7.56 Lakh ▲ 72%
Net profit · FY 2025
₹1,530 margin 0.2%
EBITDA · FY 2025
₹1,530 margin 0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 72%
3 years · compounded
▼ 22%
5 years · compounded
▼ 17%
EBITDA CAGR growth
1 year
▼ 53%
3 years · compounded
▼ 62%
5 years · compounded
▼ 47%
Revenue rose 72% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 17%. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,530 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,530 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medopex Remedies Private Limited, buy the company report.
Board of directors of Medopex Remedies Private Limited
Medopex Remedies has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priti Satish Purohit | Director | 10 Sep 2015 | 11 Years 1 Months | Current |
| Satish Indarchand Purohit | Director | 10 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
Medopex Remedies Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saivis Healthcare Private Limited | ₹7.68 Lakh (FY 2024) | 0.0% | Lucknow, Uttar Pradesh, India | |||
| Medopex Remedies Private Limitedthis company | ₹7.56 Lakh (FY 2025) | ₹1,530 | 0.2% | 72.0% | Yavatmal, Maharashtra, India | |
| Adreno Pharmaceuticals Private Limited | ₹7.54 Lakh (FY 2025) | -24.0% | Rohini New, Delhi, India | |||
| Ulabs Private Limited | ₹7.54 Lakh (FY 2024) | -94.0% | Manimajra, Chandigarh, India | |||
| Sangfroid Medi Care Private Limited | ₹7.54 Lakh (FY 2019) | -77.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of Medopex Remedies Private Limited, buy the company report.
Auditor
Medopex Remedies Private Limited is audited by NILESH SHARMA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NILESH SHARMA & CO | FY 2020 | 132308W |
Shareholding
The shareholding of Medopex Remedies Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medopex Remedies Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Mar 2022 | 100549181 | Tjsb Sahakari Bank Limited | ₹4 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medopex Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medopex Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medopex Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCM9458L1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medopex Remedies Private Limited, buy the company report.
Recent activity
Medopex Remedies Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Priti Satish Purohit was appointed as Director on 10 Sep 2015.
AGM
Medopex Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medopex Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Charges
A charge with Tjsb Sahakari Bank Limited amounted to Rs. 4.00 Lakh with Charge ID 100549181 was registered on 24 Mar 2022.
Appointed
Priti Satish Purohit was appointed as Director.
Appointed
Satish Indarchand Purohit was appointed as Director.
Incorporation
10 Sep 2015
Medopex Remedies Private Limited was registered on 10 Sep 2015 with Roc Nagpur & aged 11 years 1 month as per MCA records.
Frequently asked questions
Medopex Remedies is an active private limited company based in Yavatmal, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 September 2015 (11+ years old) and is registered under CIN U51101MH2015PTC268301.
Medopex Remedies has 2 current directors:
- Priti Satish Purohit - Director
- Satish Indarchand Purohit - Director
The latest financial statements of Medopex Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Medopex Remedies is 27AAJCM9458L1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medopex Remedies is U51101MH2015PTC268301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medopex Remedies was incorporated on 10 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Medopex Remedies by revenue are Saivis Healthcare Private Limited, Adreno Pharmaceuticals Private Limited, Ulabs Private Limited, Sangfroid Medi Care Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Priti Satish Purohit was appointed as Director on 10 Sep 2015. Satish Indarchand Purohit was appointed as Director on 10 Sep 2015.
Yes, Medopex Remedies is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-36-0011004).
The registered office of Medopex Remedies is at 28 Wadgaon Road Shradha Nagar, Yavatmal, Maharashtra, India – 445001.
Medopex Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages